Experience of COVID-19 universal screening in obstetrical units in Quebec, Canada [0.03%]
加拿大魁北克产科单位进行COVID-19普遍筛查的经验
Elisabeth McClymont,France Leduc,Isabelle Vachon et al.
Elisabeth McClymont et al.
Background: During the COVID-19 pandemic, some jurisdictions used universal screening for SARS-CoV-2 infection at obstetrical units. This study evaluated the utility of this screening strategy. ...
AMMI Canada seasonal influenza guideline update 2025-26: Some questions answered [0.03%]
加拿大2025-2026年季节性流感指南更新：一些问题解答
Robyn Harrison,Emma K Reid,Upton D Allen et al.
Robyn Harrison et al.
Antibiotic prescribing for aspiration pneumonia in the intensive care unit [0.03%]
ICU中治疗吸入性肺炎的抗生素使用方案
Elaf Alzarnougi,Mansor Binhashr,Rasha Alshawaf et al.
Elaf Alzarnougi et al.
Background: Antibiotics are frequently prescribed for aspiration pneumonia in ICU patients. We sought to determine the proportion of ICU patients treated for aspiration pneumonia who meet the diagnostic criteria. ...
Off-label use of dalbavancin to improve treatment outcomes and reduce health care costs in people who use drugs: A Canadian single-centre quality improvement initiative [0.03%]
达巴万辛的超适应症用药以改善治疗效果和降低药物使用者的医疗成本：一项加拿大的单中心质量改进倡议
Adrianna N Gunton,Mara Pavan,Victor Leung et al.
Adrianna N Gunton et al.
Background: Dalbavancin is approved in Canada for the treatment of acute bacterial skin and skin structure infections (ABSSSIs). We present a single-centre quality improvement case series of dalbavancin use in serious bac...
Diagnosis, treatment, and prophylaxis of Clostridioides difficile infections: A cross-sectional survey of Canadian clinicians [0.03%]
加拿大临床医生对艰难梭菌感染的诊断、治疗和预防的调查研究
Connor Prosty,Bennet Desormeau,Todd C Lee et al.
Connor Prosty et al.
Background: A recent international survey of clinician practices in the management of Clostridioides difficile infections (CDIs) identified numerous areas of practice heterogeneity. The degree of practice variability with...
Treatment of pre-extensively drug-resistant tuberculosis in a critically ill patient using bedaquiline, pretomanid, and linezolid therapy in Canada: A brief report [0.03%]
加拿大使用贝达喹啉、普雷托马尼和利奈唑胺治疗危重患者的广泛耐药结核病的病例报告
Hardit Singh Khuman,Philip Rodney Laird,Andrew James Willis Samis et al.
Hardit Singh Khuman et al.
Background: Pre-extensively drug-resistant tuberculosis (pre-XDR-TB) infections are rare in Canada. Drug therapies to treat pre-XDR TB are limited and acquisition of World Health Organization guideline regimens that are n...
Nonresolving oral candidiasis and squamous cell carcinoma of the tongue: Case report [0.03%]
复发性非愈合口腔白色念珠菌感染伴舌鳞癌病例报告
Lauren Shute,Rotem Keynan,Elly Trepman et al.
Lauren Shute et al.
Background: Candida species are among the most common oral fungal pathogens. Oral Candida infection may obscure the presence of tongue cancer, resulting in delayed diagnosis. ...
Penicillin allergies and community antibiotic prescriptions: A secondary analysis of prescribing choices in six family medicine clinics in southern Ontario, 2018-2019 [0.03%]
青霉烯过敏与社区抗生素处方：一项关于六家安大略省南部家庭医学诊所的开药选择的次级分析（2018-2019年）
Sahana Kukan,Warren McIsaac
Sahana Kukan
Background: While 10% of the population has a reported penicillin allergy, 90% of these allergy labels may not be accurate. However, the impact of penicillin allergy de-labelling on antibiotic use in primary care is not c...
Carbapenemase-producing hypervirulent Klebsiella pneumoniae in Alberta, Canada, 2016-2024 [0.03%]
加拿大艾伯塔省2016-2024年产碳青霉烯酶高毒力肺炎克雷伯菌
Romaine Edirmanasinghe,Tanis C Dingle,Matthew A Croxen et al.
Romaine Edirmanasinghe et al.
Background: Hypervirulent Klebsiella pneumoniae (hvKp) can cause invasive community-acquired infections in healthy adults. HvKp is usually susceptible to most antibiotics; however, multi-drug resistance, including to carb...
Using a planetary health lens to quantify intravenous use of bioequivalent antimicrobials when oral administration is feasible [0.03%]
采用行星健康视角量化口服抗菌素可行情况下的静脉注射抗生素使用量
Meghan MacLaren,Rosanne Thalakada,Hui Zhu et al.
Meghan MacLaren et al.
Background: Health care accounts for 4.6% of Canada's greenhouse gas (GHG) emissions, 25% of which comes from medications. Antimicrobials with high bioavailability offer no additional benefit when given intravenously, exc...